Yukon Choice PC

Asset

Sirolimus-eluting bioabsorbable polymer coronary stent system

Stage
Human trials
Modality
Device
Target
mTOR signalling
1
Indication
1
Trial
1
Developer

Indications

1

In the full profile

  • Targets and what it contains2
  • Owner and partners1
  • Trials1
  • Evidence for its targets2
  • Competitors1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets